The most common treatment (77.9%) for T1DM was both short and long-acting insulin analogues, used alone or in combination with other treatments, while oral anti-diabetes drugs combined with insulin was the most frequent option (60.4%) for T2DM. The gene discussed is INS; the disease is type 2 diabetes mellitus.